These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 3376456

  • 1. [Comparative evaluation of the efficacy of chemotherapy and chemoradiotherapy of stage IIIB Hodgkin's disease].
    Kanaev SV, Gershanovich ML, Malinin AP, Kholin AV.
    Vopr Onkol; 1988; 34(4):438-45. PubMed ID: 3376456
    [Abstract] [Full Text] [Related]

  • 2. [Evaluation of the effectiveness of chemoradiotherapy of stage IIIA Hodgkin's disease].
    Kanaev SV, Gershanovich ML, Malinin AP, Kholin AV.
    Med Radiol (Mosk); 1987 May; 32(5):16-21. PubMed ID: 3586917
    [Abstract] [Full Text] [Related]

  • 3. [Role of radiotherapy in the treatment of stage IIIB Hodgkin's disease in children].
    Kanaev SV, Kolygin BA, Malinin AP, Chikrizov SI.
    Med Radiol (Mosk); 1987 May; 32(5):13-5. PubMed ID: 3586916
    [Abstract] [Full Text] [Related]

  • 4. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E, Anselmo AP, Klersy C, Santoro M, Orlandi E, Pagnucco G, Lunghi F, Maurizi-Enrici R, Baroni CD, Lazzarino M, Mandelli F, Bernasconi C.
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [Abstract] [Full Text] [Related]

  • 5. Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
    Muwakkit S, Geara F, Nabbout B, Farah RA, Shabb NS, Hajjar T, Khogali M.
    Radiat Oncol Investig; 1999 Sep; 7(6):365-73. PubMed ID: 10644060
    [Abstract] [Full Text] [Related]

  • 6. [The management of Hodgkin's disease with chemotherapy or combined modality treatment].
    Tsushita K, Utsumi M, Shimoyama M.
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2202-9. PubMed ID: 9881076
    [Abstract] [Full Text] [Related]

  • 7. [The role of radiotherapy in the treatment of Hodgkin's disease].
    Saito Y, Hirose J, Chohtoh S, Nishijima H, Kobayashi A, Kamimura R, Takashima T, Ohtake S, Yoshida T, Nakamura S.
    Gan No Rinsho; 1985 Dec; 31(15):1899-904. PubMed ID: 3841562
    [Abstract] [Full Text] [Related]

  • 8. Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma.
    Vassilakopoulos TP, Angelopoulou MK, Siakantaris MP, Kontopidou FN, Dimopoulou MN, Kokoris SI, Kyrtsonis MC, Tsaftaridis P, Karkantaris C, Anargyrou K, Boutsis DE, Variamis E, Michalopoulos T, Boussiotis VA, Panayiotidis P, Papavassiliou C, Pangalis GA.
    Int J Radiat Oncol Biol Phys; 2004 Jul 01; 59(3):765-81. PubMed ID: 15183480
    [Abstract] [Full Text] [Related]

  • 9. Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation.
    Chow LM, Nathan PC, Hodgson DC, Jenkin D, Weitzman S, Grant RM, Manson D, Bross A, Doyle JJ, Danjoux C, Greenberg ML.
    J Clin Oncol; 2006 Dec 20; 24(36):5735-41. PubMed ID: 17179107
    [Abstract] [Full Text] [Related]

  • 10. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
    Liebman HA, Hum GJ, Sheehan WW, Ryden VM, Bateman JR.
    Cancer Treat Rep; 1983 May 20; 67(5):413-9. PubMed ID: 6342771
    [Abstract] [Full Text] [Related]

  • 11. [High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer].
    Avigdor A, Hardan I, Shpilberg O, Raanani P, Grotto I, Ben-Bassat I.
    Harefuah; 2000 Sep 20; 139(5-6):174-9, 248, 247. PubMed ID: 11062945
    [Abstract] [Full Text] [Related]

  • 12. Combined chemotherapy and radiotherapy for Hodgkin's disease.
    Prosnitz LR, Roberts KB.
    Oncology (Williston Park); 1992 Mar 20; 6(3):113-28; discussion 131-2, 137. PubMed ID: 1533138
    [Abstract] [Full Text] [Related]

  • 13. Pediatric Hodgkin's disease.
    Oliapuram Jose B, Koerner P, Bertolone S, Patel CC, Spanos WJ, Paris KJ, Silverman CL, Yashar CM.
    J Ky Med Assoc; 2004 Mar 20; 102(3):104-6. PubMed ID: 15067795
    [Abstract] [Full Text] [Related]

  • 14. Second malignant tumours in childhood Hodgkin's disease.
    Jenkin D, Greenberg M, Fitzgerald A.
    Med Pediatr Oncol; 1996 Jun 20; 26(6):373-9. PubMed ID: 8614372
    [Abstract] [Full Text] [Related]

  • 15. [Ten-year outcomes of lymphogranulomatosis treatment according to the protocol MOPP-ABVD+radiotherapy].
    Pivnik AV, Rastrigin NA, Moiseeva TN, Lutsenko IN, Dudarova RG, Shavlokhov VS, Efimov IV, Kozhurin SV, Shitareva IV, Gemdzhian EG, Tsyba NN, Kolosova LIu, Melikian AL, Skidan NI, Pan'shin GA, Sotnikov VM, Dotsenko PV, Nechistiuk AV.
    Ter Arkh; 2006 Jun 20; 78(8):57-62. PubMed ID: 17078219
    [Abstract] [Full Text] [Related]

  • 16. Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study.
    Salloum E, Doria R, Farber LR, Roberts KB, Cooper DL.
    Cancer J Sci Am; 1995 Jun 20; 1(4):267-73. PubMed ID: 9166487
    [Abstract] [Full Text] [Related]

  • 17. MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
    Gobbi PG, Broglia C, Levis A, La Sala A, Valentino F, Chisesi T, Sacchi S, Corbella F, Cavanna L, Iannitto E, Pavone V, Molica S, Corazza GR, Federico M.
    Clin Cancer Res; 2006 Jan 15; 12(2):529-35. PubMed ID: 16428496
    [Abstract] [Full Text] [Related]

  • 18. [Duration of second remission of Hodgkin's disease in children. Results of treatment achieved by the Polish Leukemia and Malignant Lymphoma Therapy in Children Group].
    Balwierz W, Armata J, Moryl-Bujakowska A, Depowska T, Radwańska U, Kaczmarek M, Ochocka M, Stańczak E, Sońta-Jakimczyk D, Bogusławska-Jaworska J.
    Pol Tyg Lek; 2006 Jan 15; 46(48-49):924-8. PubMed ID: 1845709
    [Abstract] [Full Text] [Related]

  • 19. Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.
    Aleman BM, Raemaekers JM, Tomiŝiĉ R, Baaijens MH, Bortolus R, Lybeert ML, van der Maazen RW, Girinsky T, Demeestere G, Lugtenburg P, Lievens Y, de Jong D, Pinna A, Henry-Amar M, European Organization for Research and Treatment of Cancer (EORTC) Lymphoma Group.
    Int J Radiat Oncol Biol Phys; 2007 Jan 01; 67(1):19-30. PubMed ID: 17097834
    [Abstract] [Full Text] [Related]

  • 20. A new combination chemotherapy for recurrent Hodgkin's lymphoma.
    Rahim MA, Sarma SK, Ahmed Q.
    Bangladesh Med Res Counc Bull; 1982 Dec 01; 8(2):63-7. PubMed ID: 6897860
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.